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Aims: The aim of this study is to target and assess possible improvements for women 
attending cervical cancer screening programs.  
 
Methods: In a randomized study the use of ThinPrep liquid based cytology (LBC) 
was tested against conventional cytology. 13 484 samples, taken within the screening 
program, were evaluated. Main outcome was cervical intraepithelial lesion grade 
two or more (CIN2+) in histopathology at follow up. A scoring system for colposcopy 
was constructed. It was tested in 297 women with abnormal cytology. The 
relationship between the scoring units and CIN was modelled with logistic 
regression. To assess the risk after treatment of CIN3 a cohort of 132 493 women with 
this diagnosis was followed up in the Swedish cancer register for development of 
vaginal or cervical cancer. Standard incidence ratios (SIR) and absolute risk 
difference were calculated. A case control study was performed to study the 
predictive ability of HPV-testing after surgery for CIN2+. Cases were 189 women 
with recurrence of CIN2+ more than two years after treatment. Exposure was 
presence of HPV in smears within two years post treatment. 
 
Results: In the LBC-arm >40% more high grade lesions were found and 30% more 
women needed follow up. Inadequacy rate of smears fell 60%. The scoring system for 
colposcopy showed very good ability to find and exclude CIN2+ at certain cut off 
points and area under ROC curve for the system was 0.87. Women treated for CIN3 
had a 2.5 times increased risk for vaginal or cervical cancer. Risk did not decrease 
substantially after 25 years and was accentuated when treatment was made in 
women older than 50. Risk also increased with time-period of treatment. Among 
women treated for CIN2-3 the odds ratio for recurrence was 2.5 when testing positive 
for HPV 6 – 12 months post surgery and sensitivity of the test was 24%. 
 
Conclusions: Liquid based cytology and a new colposcopic scoring system can 
improve detection of CIN2+. Women once treated for CIN3 constitute a high risk 
group that needs to be followed up for a long time. More studies are needed to find 
the best strategies for such follow up. 
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